|
JP6989505B2
(ja)
|
2015-08-28 |
2022-01-05 |
コーネル ユニヴァーシティー |
Ｍａｌｔ１阻害剤およびその使用
|
|
MX2018005390A
(es)
*
|
2015-11-13 |
2018-08-16 |
Novartis Ag |
Nuevos derivados de pirazolo pirimidina.
|
|
CN109562113A
(zh)
|
2016-05-10 |
2019-04-02 |
C4医药公司 |
用于靶蛋白降解的螺环降解决定子体
|
|
WO2017197046A1
(en)
|
2016-05-10 |
2017-11-16 |
C4 Therapeutics, Inc. |
C3-carbon linked glutarimide degronimers for target protein degradation
|
|
WO2017197051A1
(en)
|
2016-05-10 |
2017-11-16 |
C4 Therapeutics, Inc. |
Amine-linked c3-glutarimide degronimers for target protein degradation
|
|
ES2989988T3
(es)
|
2016-05-10 |
2024-11-28 |
C4 Therapeutics Inc |
Degronímeros heterorocíclicos para la degradación de proteínas diana
|
|
WO2018165385A1
(en)
|
2017-03-08 |
2018-09-13 |
Cornell University |
Inhibitors of malt1 and uses thereof
|
|
CN110769822A
(zh)
|
2017-06-20 |
2020-02-07 |
C4医药公司 |
用于蛋白降解的n/o-连接的降解决定子和降解决定子体
|
|
CN111278816B
(zh)
|
2017-09-04 |
2024-03-15 |
C4医药公司 |
二氢喹啉酮
|
|
CN111315735B
(zh)
|
2017-09-04 |
2024-03-08 |
C4医药公司 |
二氢苯并咪唑酮
|
|
EP3679026A1
(en)
|
2017-09-04 |
2020-07-15 |
C4 Therapeutics, Inc. |
Glutarimide
|
|
EP3710002A4
(en)
|
2017-11-16 |
2021-07-07 |
C4 Therapeutics, Inc. |
DEGRADER AND DEGRONE FOR TARGETED PROTEIN DEGRADATION
|
|
CN111770759A
(zh)
|
2017-12-28 |
2020-10-13 |
通用医疗公司 |
靶向cbm信号体复合物诱导调节性t细胞使肿瘤微环境发炎
|
|
CN111902141A
(zh)
|
2018-03-26 |
2020-11-06 |
C4医药公司 |
用于ikaros降解的羟脑苷脂结合剂
|
|
CA3096746A1
(en)
|
2018-04-12 |
2019-10-17 |
Bayer Aktiengesellschaft |
N-(cyclopropylmethyl)-5-(methylsulfonyl)-n-{1-[1-(pyrimidin-2-yl)-1h-1,2,4-triazol-5-yl]ethyl}benzamide derivatives and the corresponding pyridine-carboxamide derivatives as pesticides
|
|
CN112312904B
(zh)
|
2018-04-16 |
2025-01-07 |
C4医药公司 |
螺环化合物
|
|
SG11202009237XA
(en)
|
2018-04-23 |
2020-10-29 |
Celgene Corp |
Substituted 4-aminoisoindoline-1,3-dione compounds and their use for treating lymphoma
|
|
IL277978B2
(en)
|
2018-04-25 |
2024-07-01 |
Bayer Ag |
Novel heteroaryl-triazole and heteroaryl-tetrazole compounds as pesticides
|
|
EP3578561A1
(en)
|
2018-06-04 |
2019-12-11 |
F. Hoffmann-La Roche AG |
Spiro compounds
|
|
WO2019242625A1
(zh)
*
|
2018-06-20 |
2019-12-26 |
上海科技大学 |
制备来那度胺衍生物的方法
|
|
KR102359143B1
(ko)
|
2018-11-28 |
2022-02-08 |
다케다 야쿠힌 고교 가부시키가이샤 |
헤테로시클릭 화합물
|
|
CN120698983A
(zh)
|
2018-12-20 |
2025-09-26 |
C4医药公司 |
靶向蛋白降解
|
|
WO2020181232A1
(en)
|
2019-03-06 |
2020-09-10 |
C4 Therapeutics, Inc. |
Heterocyclic compounds for medical treatment
|
|
US20240108747A1
(en)
|
2019-03-21 |
2024-04-04 |
Lonza Sales Ag |
Extracellular vesicle conjugates and uses thereof
|
|
US12233356B2
(en)
|
2019-03-21 |
2025-02-25 |
Lonza Sales Ag |
Process for preparing extracellular vesicles
|
|
WO2020263935A1
(en)
|
2019-06-24 |
2020-12-30 |
Dana-Farber Cancer Institute, Inc. |
Hck degraders and uses thereof
|
|
EP4003973B1
(en)
|
2019-07-23 |
2024-11-20 |
Bayer Aktiengesellschaft |
Novel heteroaryl-triazole compounds as pesticides
|
|
BR112022006791A2
(pt)
|
2019-10-09 |
2022-06-28 |
Bayer Ag |
Novos compostos heteroaril-triazol como pesticidas
|
|
EP4077319A1
(en)
*
|
2019-12-20 |
2022-10-26 |
Calico Life Sciences LLC |
Protein tyrosine phosphatase degraders and methods of use thereof
|
|
MX2022007171A
(es)
*
|
2019-12-27 |
2022-08-22 |
Schroedinger Inc |
Compuestos cíclicos y métodos de uso de estos.
|
|
JP7600264B2
(ja)
*
|
2020-04-23 |
2024-12-16 |
ユニヴァーシティ オブ アイオワ リサーチ ファウンデーション |
Ｇｐｅｒタンパク質分解ターゲティングキメラ
|
|
WO2021237100A1
(en)
|
2020-05-21 |
2021-11-25 |
Codiak Biosciences, Inc. |
Methods of targeting extracellular vesicles to lung
|
|
US20230192685A1
(en)
|
2020-05-27 |
2023-06-22 |
Takeda Pharmaceutical Company Limited |
Method for producing heterocyclic compound
|
|
AU2021293907A1
(en)
*
|
2020-06-17 |
2023-01-19 |
Dana-Farber Cancer Institute, Inc. |
Targeted aberrant alpha-synuclein species and induced ubiquitination and proteosomal clearance via co-recruitment of an E3-ligase system
|
|
US20230235077A1
(en)
|
2020-06-24 |
2023-07-27 |
The General Hospital Corporation |
Materials and methods of treating cancer
|
|
WO2022066928A2
(en)
|
2020-09-23 |
2022-03-31 |
Codiak Biosciences, Inc. |
Process for preparing extracellular vesicles
|
|
US20230414629A1
(en)
*
|
2020-11-12 |
2023-12-28 |
Monopteros Therapeutics, Inc. |
Materials and methods of treating cancer
|
|
MX2023008296A
(es)
|
2021-01-13 |
2023-09-29 |
Monte Rosa Therapeutics Inc |
Compuestos de isoindolinona.
|
|
AU2022212823A1
(en)
|
2021-01-29 |
2023-08-10 |
Eurofins Discoverx Corporation |
Molecular glue screening assays and methods for practicing same
|
|
AU2022425324A1
(en)
|
2021-12-30 |
2024-05-30 |
Jiangsu Hansoh Pharmaceutical Group Co., Ltd. |
Tricyclic derivative inhibitor, preparation method therefor, and application thereof
|
|
KR20240136392A
(ko)
*
|
2022-01-18 |
2024-09-13 |
오리진 온콜로지 리미티드 |
Malt-1 억제제로서의 치환된 바이사이클릭 헤테로사이클
|
|
CN118525021A
(zh)
*
|
2022-01-28 |
2024-08-20 |
上海齐鲁制药研究中心有限公司 |
靶向malt1的蛋白降解化合物
|
|
JPWO2023149450A1
(enExample)
|
2022-02-02 |
2023-08-10 |
|
|
|
US20250163066A1
(en)
*
|
2022-02-25 |
2025-05-22 |
Tegid Therapeutics, Inc. |
PROTACs of MALT1
|
|
EP4536656A1
(en)
|
2022-06-06 |
2025-04-16 |
C4 Therapeutics, Inc. |
Bicyclic-substituted glutarimide cereblon binders
|